Tech Center 1600 • Art Units: 1653 1657
This examiner grants 51% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16604138 | ENGINEERED COMMENSAL BACTERIA AND METHODS OF USE | Non-Final OA | The Regents of the University of California |
| 17955413 | PREBIOTIC FORMULATIONS | Final Rejection | Ohio State Innovation Foundation |
| 17172528 | CELL CULTURE STRATEGIES FOR MODULATING PROTEIN GLYCOSYLATION | Final Rejection | GENENTECH, INC. |
| 17605374 | GENE TARGETS FOR NITROGEN FIXATION TARGETING FOR IMPROVING PLANT TRAITS | Non-Final OA | Pivot Bio, Inc. |
| 18047384 | METHOD FOR ESTIMATING CULTURE STATE, INFORMATION PROCESSING DEVICE, AND PROGRAM | Final Rejection | FUJIFILM Corporation |
| 18064511 | COLORIMETRIC ASSAY FOR HIGH THROUGHPUT, FACILE AND RAPID ANTIMICROBIAL SUSCEPTIBILITIES TESTING | Final Rejection | Georgia Tech Research Corporation |
| 17608274 | FEED COMPOSITIONS CONTAINING BETAINE SALTS | Non-Final OA | Evonik Operations GmbH |
| 14898679 | METHOD FOR STORING EXCESS ENERGY | Non-Final OA | Evonik Operations GmbH |
| 17920893 | MICROVESICLE ISOLATION METHOD AND MICROVESICLE ISOLATION | Final Rejection | Korea University Research and Business Foundation |
| 18022201 | Label-free, real-time, whole-cell response monitoring with liquid Raman spectroscopy | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17698257 | AGENT FOR PROMOTING COLLAGEN PRODUCTION, MEDICAMENT, COSMETIC, AND METHOD FOR MANUFACTURING AGENT FOR PROMOTING COLLAGEN PRODUCTION | Final Rejection | Murata Manufacturing Co., Ltd. |
| 19067759 | NOVEL METHOD TO ALTER THE PROTEOME OF A DISEASED HEART BY INJECTION OF ECM PARTICLES PRODUCED FROM DECELLULARIZED 3D MICROTISSUES OF HUMAN MESENCHYMAL STEM CELLS | Non-Final OA | XM Therapeutics, Inc. |
| 17919142 | METHODS AND SYSTEMS OF ENHANCING OPTICAL SIGNALS OF EXTRACELLULAR VESICLES | Final Rejection | The General Hospital Corporation |
| 19028716 | STRAIN OF ENTEROCOCCUS FAECALIS, COMPOSITE BACTERIAL AGENT AND APPLICATIONS THEREOF | Final Rejection | HEALTH AND HAPPINESS (H&H) HONG KONG LIMITED |
| 18629273 | DIAGNOSIS AND TREATMENT OF FUSARIOSIS AND SCEDOSPORIOSIS | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 18985909 | METHOD FOR ENHANCING IMMUNE SYSTEM FUNCTIONS IN A SUBJECT | Final Rejection | Macularity, Inc. |
| 17801002 | METHODS FOR REHABILITATING HEART FAILURE USING GENE THERAPY | Non-Final OA | UNIVERSITY OF UTAH RESEARCH FOUNDATION |
| 18861561 | PROBIOTICS FOR THE PREVENTION OR TREATMENT OF VIRAL RESPIRATORY INFECTIONS | Non-Final OA | SUPERBIOTICS SRL |
| 17736430 | METHOD FOR PRODUCING COLLAGEN PEPTIDES FROM BONES, AND PRODUCED COLLAGEN PEPTIDES | Non-Final OA | GELITA AG |
| 15474723 | PROBIOTIC COMPOSITIONS AND METHODS | Final Rejection | CORNELL UNIVERSITY |
| 17755955 | COMPOSITIONS, KITS AND METHODS FOR STORAGE OF BLOOD PRODUCTS AND METHODS OF USE THEREOF | Final Rejection | Rutgers, The State University of New Jersey |
| 16866154 | POLYHYDROXYALKANOATE PRODUCTION METHOD | Final Rejection | Newlight Technologies, Inc. |
| 17760615 | SEAWEED-BASED COMPOSITION | Final Rejection | Cargill, incorporated |
| 18591819 | HOST-BIOME INTERACTIONS | Non-Final OA | Emulate, Inc. |
| 18532577 | MANIPULATION OF TRYPTAMINE METABOLISM | Final Rejection | Seres Therapeutics, Inc. |
| 17642328 | METHODS FOR REDUCTION OF BITTERNESS IN CANNABINOIDS USING MYCELIAL MATERIALS | Non-Final OA | MYCOTECHNOLOGY, INC. |
| 17640456 | Method For Capturing And Purification Of Biologics | Final Rejection | Amicus Therapeutics, Inc. |
| 18283424 | SPIRULINA-BASED COMPOSITION AND USES THEREOF FOR REINFORCING IMMUNITY | Non-Final OA | Axeen Pharma |
| 18260421 | USE OF DEOXYRIBONUCLEASE I IN THE TREATMENT OF ENDOMETRIOSIS IN PATIENTS WITH AN EPIGENETIC SIGNATURE OF ENDOMETRIOSIS ON CELL-FREE DNA | Non-Final OA | Endolife |
| 18252560 | AIR MONITORING SYSTEMS AND METHODS | Non-Final OA | U-EARTH BIOTECH LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy